UGRSTM
Surgical treatment of Peyronie's disease

Surgical Treatment of Peyronie's Disease (Induratio Penis Plastica)

For 30 years. Evidence-based. Performed personally by Prof. Agustín Fraile Poblador.

Many men first notice a spontaneous change – a slight curvature, a hardened area, or an unfamiliar pain. What initially seems like a temporary problem can develop into a lasting burden. This page gives you an honest, medical overview: what the condition is, what treatments are available – and when surgery may make sense.

Prof. Agustín Fraile Poblador

Medically Reviewed By: Prof. Agustín Fraile Poblador

Jörg Hagen

Editorial Review: Jörg Hagen, Lead Physician

Updated on July 31, 2026

What Is Peyronie's Disease?

Peyronie's disease – medically known as Induratio Penis Plastica (IPP) – is a benign condition of the penis in which scar-like hardened areas form in the lining of the erectile tissue (tunica albuginea). These hardened areas are known as plaques.

Because the affected tissue loses its normal elasticity, the penis can no longer expand evenly during erection. The result is curvature, indentations, or other changes in shape – in some cases also a noticeable shortening.

Although the condition is benign, it can have a considerable impact on quality of life – both physically and psychologically. Many affected men go a long time without talking to anyone about it. However, an early medical assessment can help you better understand the situation and take the right next steps.

Treatment of Peyronie's disease at UGRS Center Darmstadt is provided by physicians Agustín Fraile Poblador and Alessandro Perotti, depending on the leading symptom. Two specialists with many years of experience in the diagnosis and surgical treatment of this condition.

Prof. Agustín Fraile Poblador and Dott. Alessandro Perotti

Peyronie's Disease at a Glance

Before we go into more depth, we would like to give you an initial overview.

Condition

Benign connective tissue disorder of the penis

Typical symptoms

Curvature, hardening, pain, shortening, erectile problems

Prevalence

Approximately 5% of men affected

Typical age

Often between 40 and 60 years of age

Course

Often progressive; occurs in phases

Diagnostics

Physical examination, ultrasound, supplementary imaging

Treatment

Conservative or surgical procedures, depending on stage and symptoms

The first step isn't a procedure – it's a conversation.

Jörg Hagen

Your personal point of contact, Mr Jörg Hagen, Medical Director of UGRS International GmbH, is happy to answer your questions about the treatment and its process.

+49 6151 606 1034+49 152 275 552 37kontakt@ugrs.de

Monday to Friday

9:30 AM – 7:00 PM

or by individual arrangement

Show contents

Symptoms of Peyronie's Disease – What Patients Experience

The symptoms of Peyronie's disease can vary widely in severity. Typical symptoms include:

  • Curvature of the penis during erection
  • Palpable hardening or nodules in the penile shaft
  • Pain during or after erection
  • Shortening of the penis
  • Indentations or so-called hourglass deformities
  • Erectile dysfunction

Not every patient develops all symptoms. The extent and combination of symptoms vary from person to person – and are decisive for choosing the right treatment.

Course of the Disease

Active Phase

In the active phase, the changes develop. Pain may occur, the curvature can increase, and new hardened areas can form. This phase typically lasts several months to about a year.

Stable Phase

As the condition progresses, it often moves into a more stable phase. The curvature then usually changes only slightly – however, the existing changes remain and generally do not resolve on their own.

Spontaneous healing is very rare. In many cases, waiting worsens the symptoms and makes later treatment more difficult. Early medical assessment is therefore advisable.

Causes of Peyronie's Disease and Risk Factors

The exact causes of Peyronie's disease are still not fully understood. According to current understanding, it is a disorder of wound healing and connective tissue metabolism – resulting in excessive scar formation within the lining of the erectile tissue.

Various factors appear to increase the risk:

  • Genetic predisposition
  • Connective tissue disorders (e.g. Dupuytren's contracture of the hand)
  • Repeated microtrauma to the penis
  • Certain surgical procedures in the pelvic area
  • Metabolic diseases such as diabetes

Important: Patients with Dupuytren's contracture should also be examined for IPP – and vice versa. Early treatment of both conditions improves outcomes.

Psychological Burden – An Underestimated Aspect

The physical changes associated with Peyronie's disease are often only part of the problem. Many affected men report that the psychological burden weighs at least as heavily as the physical symptoms themselves. This is partly because IPP affects a very personal and intimate area of life – and that leaves a clear mark on many patients.

In conversations with our patients, similar themes come up again and again. Affected men frequently report a fear of rejection in intimate situations, which over time can lead to feelings of shame and outright withdrawal from relationships. This is often accompanied by a loss of self-confidence and self-esteem, along with fundamental concerns about one's own masculinity. These burdens rarely remain limited to the person affected – they frequently also affect the partnership and can, in some cases, extend to depressive moods.

For this reason, we always take a holistic approach to treating Peyronie's disease at UGRS. During the consultation, we deliberately don't just talk about the physical situation, but also take time for the psychological dimension – because only by keeping both sides in view can we truly help those affected.

Diagnosis of Peyronie's Disease – The First Step Is Not a Procedure

Many men come to us with one question: Do I need surgery? The honest answer is: not necessarily. Diagnosis begins with a detailed conversation and a physical examination. Depending on the situation, this is supplemented by ultrasound, blood-flow diagnostics, or MRI.

Overview of Treatment Options for Peyronie's Disease

Conservative Treatments

Many men come to us with one question: Do I need surgery? The honest answer is: not necessarily. Diagnosis begins with a detailed conversation and a physical examination. Depending on the situation, this is supplemented by ultrasound, blood-flow diagnostics, or MRI.

Surgical Treatments

Several methods are available for surgical treatment – ranging from shortening procedures (Nesbit, Essed-Schröder) to grafting techniques and microsurgical plaque removal with biological reconstruction, as performed at UGRS.

Our Surgical Method

At UGRS Center Darmstadt, we follow a reconstructive approach: microsurgical removal of the affected tissue (plaque) followed by biological reconstruction – primarily using the patient's own oral mucosa, and in selected cases, a biodegradable collagen fleece. No permanent artificial material is used.

The goal is not straightening alone – but the most comprehensive treatment possible: correcting the curvature, preserving penile length, restoring elasticity, and preserving erectile function.

This procedure is designated in the EAU guidelines as the preferred approach for pronounced curvatures. It requires specialized experience – and is led by Prof. Agustín Fraile Poblador.

Costs and Reimbursement

Surgical treatment of Peyronie's disease at UGRS costs approximately €14,500, including all services. As a private medical service, it is not covered by German statutory health insurance (GKV). However, there is a little-known reimbursement option under European law – in certain cases, up to 90% may be possible.

For full details on costs, insurance coverage, and reimbursement options, please contact us directly.

Risks and Healing Process

As with any operation, surgical treatment of IPP carries risks. General risks include secondary bleeding, wound-healing disorders, and infections. Specific risks associated with reconstructive procedures include residual curvature and changes in erectile function.

The healing process varies from patient to patient. The final result can only be assessed after several months. Structured aftercare is a fixed part of our treatment concept.

When Is a Second Opinion Advisable?

Peyronie's disease is one of the more complex conditions in reconstructive urology. Particularly in cases of pronounced curvature, conflicting treatment recommendations, or planned surgery, an independent second opinion can be very valuable. Many of our patients come to us in exactly this situation – and that too is welcome.

Our Experience, Your Advantage

30 Years – And a Track Record That Proves It

The choice of surgeon is one of the most important decisions patients make.

UGRS Center Darmstadt has more than 30 years of experience in reconstructive surgery of the male genital area. Treatment of Peyronie's disease is led by Prof. Agustín Fraile Poblador.

  • Over 30 years of experience in reconstructive genital surgery
  • Specialization in microsurgical reconstruction techniques
  • Biological reconstruction approach – no artificial materials
  • Holistic treatment concept: function, form, and psychological well-being
  • Discreet consultation, confidential atmosphere

You don't have to figure this out alone.

The decision to undergo surgical treatment for Peyronie's disease is always a personal one. Our goal is not to convince you to have a procedure – but to give you an honest basis on which you can decide for yourself.

Many of our patients didn't dare bring up this topic for years. The first step isn't a procedure – it's a conversation.

Write to us, call us, or book an appointment online for an initial conversation.

The first step isn't a procedure – it's a conversation.

Jörg Hagen

Your personal point of contact, Mr Jörg Hagen, Medical Director of UGRS International GmbH, is happy to answer your questions about the treatment and its process.

+49 6151 606 1034+49 152 275 552 37kontakt@ugrs.de

Monday to Friday

9:30 AM – 7:00 PM

or by individual arrangement

Or send us your question. If you'd like a callback, feel free to add your phone number and a time when you can be reached.

Sources & References

  1. 1. Ziegelmann MJ, Bajic P, Levine LA. (2020) Peyronie’s disease: Contemporary evaluation and management. Int J Urol. 2020 Jun;27(6):504-516.
    DOI: 10.1111/iju.14230 PubMed: 32253786
  2. 2. Roadman D, Wang V, Beer A, Levine L. (2024) A contemporary assessment of the evaluation and management of patients presenting to a tertiary medical center with Peyronie’s disease. Int J Impot Res. 2024 Apr;36(2):118-124.
    DOI: 10.1038/s41443-023-00738-w PubMed: 37468535
  3. 3. Cosentino M, Di Nauta M, Boeri L, Ferraioli G, Lucignani G, Ricapito A, Gadda F, Iafrate M, Mancini M, Dal Moro F, Ruiz-Castañe E, Bettocchi C, Montanari E, Sofikitis N. (2024) Conservative treatment of Peyronie’s disease: a guide. World J Urol. 2024 May 13;42(1):317.
    DOI: 10.1007/s00345-024-04975-6 PubMed: 38740620
  4. 4. Anderson D, Laforge J, Ross MM, Vanlangendonck R, Hasoon J, Viswanath O, Kaye AD, Urits I. (2022) Male Sexual Dysfunction. Health Psychol Res. 2022 Aug 20;10(3):37533.
    DOI: 10.52965/001c.37533 PubMed: 35999971
  5. 5. Reddy AG, Dai MC, Song JJ, Pierce HM, Patel SR, Lipshultz LI. (2023) Peyronie’s Disease: An Outcomes-Based Guide to Non-Surgical and Novel Treatment Modalities. Res Rep Urol. 2023 Feb 2;15:55-67.
    DOI: 10.2147/RRU.S278796 PubMed: 36756281
  6. 6. Mesquita FC, Barros R, Lima TFN, Velasquez D, Favorito LA, Pozzi E, Dornbush J, Miller D, Petrella F, Ramasamy R. (2024) Evidence of restorative therapies in the treatment of Peyronie disease: A narrative review. Int Braz J Urol. 2024 Nov-Dec;50(6):703-713.
    DOI: 10.1590/S1677-5538.IBJU.2024.9920 PubMed: 39133793
  7. 7. Alshuaibi M, Zugail AS, Lombion S, Beley S. (2024) New protocol in the treatment of Peyronie’s disease by combining platelet-rich plasma, percutaneous needle tunneling, and penile modeling: Preliminary results. Fr J Urol. 2024 Jan;34(1):102526.
    DOI: 10.1016/j.purol.2023.09.013 PubMed: 37777436
  8. 8. Li EV, Esterquest R, Pham MN, Panken EJ, Amarasekera C, Siebert A, Bajic P, Levine LA. (2021) Peyronie’s disease: pharmacological treatments and limitations. Expert Rev Clin Pharmacol. 2021 Jun;14(6):703-713.
    DOI: 10.1080/17512433.2021.1903873 PubMed: 33719851
  9. 9. Aditya I, Kwong JCC, Krakowsky Y, Grober ED. (2020) Non-conventional therapies for Peyronie’s disease: what is the evidence for efficacy? Transl Androl Urol. 2020 Mar;9(Suppl 2):S295-S302.
    DOI: 10.21037/tau.2019.09.36 PubMed: 32257870
  10. 10. Abdel Fattah AAE, Diab T, El-Dakhakhny AS, El Hamshary SA. (2024) Intralesional injection of h.a. compared with v. in acute phase of Peyronie’s disease: A prospective randomized clinical trial. Arab J Urol. 2024 Mar 22;22(4):206-211.
    DOI: 10.1080/20905998.2024.2333583 PubMed: 39355797
  11. 11. Kadıoğlu A, Gürcan M, Rakhmonovich AF, Dursun M. (2024) Surgical management of complex curvature in Peyronie’s disease. World J Urol. 2024 Apr 30;42(1):276.
    DOI: 10.1007/s00345-024-04936-z PubMed: 38689034
  12. 12. Chung E. (2020) Penile Reconstructive Surgery in Peyronie Disease: Challenges in Restoring Normal Penis Size, Shape, and Function. World J Mens Health. 2020 Jan;38(1):1-8.
    DOI: 10.5534/wjmh.170056 PubMed: 29623703
  13. 13. Rajamohan N, Kapoor H, Khurana A, Nelson L, Ganesh HS, Khatri G, Nair RT. (2025) MR imaging of penile pathology and prostheses. Abdom Radiol (NY). 2025 Jan;50(1):305-318.
    DOI: 10.1007/s00261-024-04417-2 PubMed: 39066812
  14. 14. Şahin A, Babayev H, Cirigliano L, Preto M, Falcone M, Altıntas E, Gül M. (2024) Unveiling the molecular Hallmarks of Peyronie’s disease: a comprehensive narrative review. Int J Impot Res. 2024 Dec;36(8):801-808.
    DOI: 10.1038/s41443-024-00845-2 PubMed: 38454161
  15. 15. Goldstein I, Hartzell R, Shabsigh R. (2016) The Impact of Peyronie’s Disease on the Patient: Gaps in Our Current Understanding. J Sex Marital Ther. 2016;42(2):178-90.
    DOI: 10.1080/0092623X.2014.985351 PubMed: 25405853
  16. 16. Lee HY, Pyun JH, Shim SR, Kim JH. (2024) Medical Treatment for Peyronie’s Disease: Systematic Review and Network Bayesian Meta-Analysis. World J Mens Health. 2024 Jan;42(1):133-147.
    DOI: 10.5534/wjmh.230016 PubMed: 37382281
  17. 17. Nugteren HM, Nijman JM, de Jong IJ, van Driel MF. (2011) The association between Peyronie’s and Dupuytren’s disease. Int J Impot Res. 2011 Jul-Aug;23(4):142-5.
    DOI: 10.1038/ijir.2011.18 PubMed: 21633367
  18. 18. Shindel AW, Sweet G, Thieu W, Durbin-Johnson B, Rothschild J, Szabo R. (2017) Prevalence of Peyronie’s Disease-Like Symptoms in Men Presenting With Dupuytren Contractures. Sex Med. 2017 Sep;5(3):e135-e141.
    DOI: 10.1016/j.esxm.2017.06.001 PubMed: 28676223
  19. 19. Dullea A, Efimenko I, Firdaus F, Griswold A, Arora H, Masterson T, Ramasamy R. (2022) Men With Both Peyronie’s and Dupuytren’s Disease. Urology. 2022 Aug;166:76-78.
    DOI: 10.1016/j.urology.2022.02.023 PubMed: 35292292

Author

Jörg Hagen

Jörg Hagen

UGRS Management

Doctor Profile

Medically Reviewed By

Prof. Agustín Fraile Poblador

Prof. Agustín Fraile Poblador

Urologist, Andrology, Reconstructive Uro-Surgery

Doctor Profile